First human tests begin for new fatty liver disease drug
NCT ID NCT07407634
Summary
This is an early-stage study to test the safety of a new drug called XTYW007 in healthy volunteers and people with high 'bad' cholesterol (LDL-C). Researchers will give single and multiple doses to see how the body handles the drug, check for side effects, and see if food changes how it works. They will also take preliminary measurements to see if it affects blood cholesterol and other fats.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC FATTY LIVER DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The First Hospital of Jilin University
Jilin, Changchun, China
Conditions
Explore the condition pages connected to this study.